Fiche publication
Date publication
octobre 2024
Journal
Minerva urology and nephrology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr TRICARD Thibault
Tous les auteurs :
Martini A, Bernhard JC, Falagario UG, Herman G, Geshkovska A, Khene ZE, Audenet F, Champy C, Bruyere F, Rolland M, Waeckel T, Lorette M, Doumerc N, Surlemont L, Parier B, Tricard T, Branger N, Michel C, Fiard G, Fontenil A, Vallée M, Guillotreau J, Patard JJ, Joncour C, Boissier R, Ouzaid I, Panthier F, Belas O, Mallet R, Gimel P, DE Vergie S, Bigot P, Beauval JB
Lien Pubmed
Résumé
In 2021, the EAU Guidelines implemented a novel, expert opinion-based follow-up scheme, with a three-risk-category system for clear cell (cc) and non-cc renal cell carcinoma (non-ccRCC) after surgery with curative intent. We aimed to validate the novel follow-up scheme and provide data-driven recurrence estimates according to risk groups, to confirm or implement the oncologic surveillance strategy.
Mots clés
Humans, Kidney Neoplasms, surgery, Male, Female, Middle Aged, Aged, Neoplasm Recurrence, Local, prevention & control, Carcinoma, Renal Cell, surgery, Risk Assessment, methods, Nephrectomy, methods, Follow-Up Studies, Prospective Studies, Population Surveillance, methods
Référence
Minerva Urol Nephrol. 2024 10;76(5):578-587
